Urinary NO3 excretion and renal failure in indinavir-treated patients
AUTOR(ES)
Eira, M., Araujo, M., Seguro, A.C.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2006-08
RESUMO
Treatment with indinavir (IDV), a protease inhibitor, is frequently associated with renal abnormalities. We determined the incidence of renal failure (creatinine clearance <80 mL min-1 1.73 (m²)-1) in HIV patients treated with highly active antiretroviral therapy, including IDV, and investigated the possible mechanisms and risk factors of IDV nephrotoxicity. Thirty-six patients receiving IDV were followed for 3 years. All were assessed for age, body weight, duration of infection, duration of IDV treatment, sulfur-derivative use, total cholesterol, triglycerides, magnesium, sodium, potassium, creatinine, and urinalysis. We also determined renal function in terms of creatinine clearance, urine osmolality and fractional excretion of sodium, potassium, and water. Urinary nitrate (NO3) excretion was measured in 18 IDV-treated patients and compared with that of 8 patients treated with efavirenz, a drug without renal side effects. Sterile leukocyturia occurred in 80.5% of the IDV-treated patients. Creatinine clearance <80 mL min-1 1.73 (m²)-1 was observed in 22 patients (61%) and was associated with low body weight and the use of sulfur-derivatives. These patients also had lower osmolality, lower urine volume and a higher fractional excretion of water compared to the normal renal function group. Urinary NO3 excretion was significantly lower in IDV-treated patients (809 ± 181 µM NO3-/mg creatinine) than in efavirenz-treated patients (2247 ± 648 µM NO3-/mg creatinine, P < 0.01). The lower NO3 excretion suggests that IDV decreases nitric oxide production.
Documentos Relacionados
- Effect of castration on renal glycosaminoglycans and their urinary excretion in male and female rats with chronic renal failure
- Alterations in renal function in HIV/AIDS patients treated with therapeutic regimens including indinavir
- Platelet factor 3 in normal subjects and patients with renal failure
- RENAL CIRCULATORY DYNAMICS AND URINARY PROTEIN EXCRETION DURING INFUSIONS OF l-NOREPINEPHRINE AND l-EPINEPHRINE IN PATIENTS WITH RENAL DISEASE 12
- The effect of glutamine administration on urinary ammonium excretion in normal subjects and patients with renal disease